Amedisys Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Amedisys, Inc. (AMED) Thwomps Q2 Profit Views
July 30, 2014 7:21 AM EDTAmedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.25, $0.21 better than the analyst estimate of $0.04. Revenue for the quarter came in at $305 million versus the consensus estimate of $298.9 million.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
... More